pimagedine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JS | 1 |
| Cha, SH | 1 |
| Kim, WS | 1 |
| Han, SJ | 1 |
| Cha, SB | 1 |
| Kim, HM | 1 |
| Kwon, KW | 1 |
| Kim, SJ | 1 |
| Choi, HH | 1 |
| Lee, J | 1 |
| Cho, SN | 1 |
| Koh, WJ | 1 |
| Park, YM | 1 |
| Shin, SJ | 1 |
1 other study available for pimagedine and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus.
Topics: Animals; Cell Communication; Cytokines; Dinoprostone; Guanidines; Macrophages; Mesenchymal Stem Cell | 2016 |